Peter C. Hou/Brigham and Women's Hospital
Aug 8, 2025, 12:37
Auxora in Severe COVID-19: Phase 2 Trial Reveals D-Dimer Reduction Benefits
Thrombosis Update shared an insightful post on X:
“New article in Thrombosis Update. Findings from a phase 2 trial show that Auxora may help patients with severe COVID-19 by reducing D-dimer levels.”
Read the full article here.
Title: Reduction in D-dimer levels after treatment with Auxora in patients with severe COVID-19 pneumonia
Authors: Peter C. Hou, Joseph Miller, Charles Bruen, Fady Youssef, Michael J. Schnaus, Kathyrn Brouillette, Raul Mendoza-Ayala, Jeffrey Zhang, Kenneth Stauderman, Sudarshan Hebbar
Discover the latest advancements in thrombosis and hemostasis research on Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology